one.bio is an emerging biotechnology spinout from UC Davis that creates ingredients for food and biopharmaceutical applications.
one.bio has raised $27.0M in total funding. The most recent round was Series A. The last funding was announced in December 2024.
one.bio's investors include Bill & Melinda Gates Foundation, K5 Global, Alpha Edison, Seventure Partners, Collaborative Fund.
one.bio is headquartered in Sacramento, United States.
one.bio is an emerging biotechnology spinout from UC Davis that creates ingredients for food and biopharmaceutical applications.
one.bio is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"one.bio — Funding & Investors." VCBacked, December 12, 2024, https://www.vcbacked.co/company/onebio. Accessed July 20, 2026.
VCBacked. (2024). one.bio — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/onebio
{{cite web |title=one.bio — Funding & Investors |url=https://www.vcbacked.co/company/onebio |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated